Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 156 of its Phase 3 PaTHway Trial confirming that long-term treatment with ...

While strokes are widely recognized as a major cause of long-term disability in the United States, their quieter cousin, the ...

Introduction Adolescent idiopathic scoliosis (AIS) often imposes a significant psychological burden on teenagers. Cognitive and behavioural strategies have demonstrated the potential to alleviate ...

Brain dynamics and cognition share genetic roots. Criticality may guide future brain health research. A recent study published on June 24 in PNAS presents strong evidence that brain criticality—the de ...

Entering your mid-20s marks a time of transition, self-discovery, and newfound independence. As you enter young adulthood, ...

Nearly a third of people in the UK are sexually inactive – but could it be good for you or is it harmful to your overall ...

As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...

Since the emergence of the Zika virus epidemic in 2014 and the associated novel sequalae that emerged, much has been learned about the effects of antenatal exposure to Zika virus. Zika virus in ...

The diagnostic category of adult ADHD is becoming more inclusive. That’s not the same as it being overdiagnosed ...

In the Phase 2 MINDFuL trial of XPro in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat (mITT) population (n=200) did not meet the primary co ...